title: Heart transplant rejection with hemodynamic compromise: a multiinstitutional study of the role of endomyocardial cellular infiltrate. Cardiac Transplant Research Database.
abstract: BACKGROUND
  The natural history of patients experiencing hemodynamic compromise with rejection has been incompletely characterized. This multiinstitutional study examined the outcome of such episodes, particularly with regard to the extent of cellular infiltrate on the index endomyocardial biopsy.
  
  
  METHODS
  From January 1, 1990, through June 30, 1994, 3367 patients in the Cardiac Transplant Research Database experienced 4137 episodes of rejection. Severe hemodynamic compromise occurred in approximately 5% of the rejection episodes, and this proportion remained relatively constant over time.
  
  
  RESULTS
  Recipient risk factors for rejection with severe hemodynamic compromise included black race, female recipient sex, and diabetes. The 3-month actuarial survival rate was 60% after rejection with severe hemodynamic compromise versus 95% after rejection with no or mild compromise. Low initial biopsy score conferred a higher early survival, but a lower survival at 2 years after rejection with severe hemodynamic compromise. Among patients who survive an initial rejection episode with severe hemodynamic compromise, survival at 2 years after an episode was 46% among those who had a low initial biopsy score versus 84% with a high biopsy score.
  
  
  CONCLUSIONS
  Rejection with hemodynamic compromise, although rare, represents a major complication of heart transplantation with a poor long-term outcome. Survivors of hemodynamically compromising rejection episodes associated with low biopsy scores in the International Society for Heart and Lung Transplantation grading system have a significantly worse long-term outcome than survivors of episodes associated with high scores. These findings suggest that immunologic mechanisms other than lymphocytic infiltration of the cardiac allograft are important and distinct causes of allograft dysfunction.
authors.affiliation: University of Kentucky, Lexington, USA.
authors.forename: R M
authors.initials: RM
authors.lastname: Mills
authors.forename: D C
authors.initials: DC
authors.lastname: Naftel
authors.forename: J K
authors.initials: JK
authors.lastname: Kirklin
authors.forename: A B
authors.initials: AB
authors.lastname: Van Bakel
authors.forename: B E
authors.initials: BE
authors.lastname: Jaski
authors.forename: E K
authors.initials: EK
authors.lastname: Massin
authors.forename: H J
authors.initials: HJ
authors.lastname: Eisen
authors.forename: F A
authors.initials: FA
authors.lastname: Lee
authors.forename: D P
authors.initials: DP
authors.lastname: Fishbein
authors.forename: R C
authors.initials: RC
authors.lastname: Bourge
mesh_terms: D000206:Actuarial Analysis; D000328:Adult; D001706:Biopsy; D044383:Black People; D002423:Cause of Death; D004699:Endocardium / Q000473:pathology; D004719:Endomyocardial Fibrosis / Q000401:mortality / Q000473:pathology*; D005260:Female; D006084:Graft Rejection / Q000401:mortality / Q000473:pathology*; D006333:Heart Failure / Q000401:mortality / Q000473:pathology*; D016027:Heart Transplantation / Q000401:mortality / Q000473:pathology*; D006439:Hemodynamics / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000473:pathology; D012307:Risk Factors; D015996:Survival Rate